Trial Profile
Clinical Trials Insight: 700028279
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2007
Price :
$35
*
At a glance
- Drugs Aclidinium bromide (Primary)
- Indications Bronchoconstriction; Chronic obstructive pulmonary disease
- Focus Pharmacodynamics
- Sponsors Almirall S.A.
- 08 Nov 2007 New trial record.